Horsetail

Metadata

Important botanical safety note: Equisetum arvense (field horsetail) must be carefully distinguished from Equisetum palustre (marsh horsetail), which contains toxic palustrine alkaloids. Correct identification is essential.

Approved Indications

Commission E (Germany)

• Approved: Post-traumatic and static edema; irrigation therapy for bacterial and inflammatory diseases of the lower urinary tract and renal gravel

ESCOP

• Approved: Irrigation therapy for bacterial and inflammatory conditions of the lower urinary tract and for renal gravel
• Also: adjuvant treatment of wounds (external)

EMA/HMPC

• Traditional Use: Two indications:
  1. To increase urine production to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints
  2. For treatment of superficial wounds (external use)
• Based on traditional use (30+ years including 15+ years in EU)

Agreement/Disagreement

• Good agreement between Commission E, ESCOP, and HMPC on irrigation therapy indication
• Commission E uniquely includes post-traumatic/static edema
• All bodies classify this as “traditional use” — no “well-established use” designation
• US: Not recognized in mainstream medicine; known in naturopathic practice

Conditions Treated

• Irrigation therapy for:
  • Bacterial infections of the lower urinary tract (adjunctive)
  • Inflammatory conditions of the lower urinary tract
  • Renal gravel
• Post-traumatic and static edema
• Superficial wounds (external application)
• Traditional uses also include: brittle nails, hair loss, osteoporosis support (silica-based; not regulatory-approved)

Mechanism of Action

Primary Mechanisms

1. Aquaretic / Diuretic Effect

   • Increases urine volume without significant electrolyte loss (aquaretic)
   • Mechanism not fully elucidated; likely multifactorial
   • Flavonoids and phenolic acids may contribute to increased glomerular filtration
   • Carneiro 2014 demonstrated diuretic effect equivalent to hydrochlorothiazide without electrolyte changes

2. Anti-inflammatory Activity

   • Flavonoid content contributes to anti-inflammatory effects
   • Phenolic compounds (caffeic acid derivatives) with antioxidant/anti-inflammatory activity

3. Silica Contribution

   • Horsetail contains 5-10% silicic acid (as silica, SiO2)
   • Silica is believed to support connective tissue integrity
   • May contribute to urinary tract tissue repair
   • The silica content is the basis for traditional use in bone/nail/hair health

4. Antioxidant Activity

   • Phenolic compounds provide antioxidant protection
   • May reduce oxidative stress in inflamed urinary tract tissue

5. Antihypertensive Effect [EMERGING]

   • A 2022 double-blind RCT suggested antihypertensive effects
   • Mechanism may involve diuretic action + vascular effects
   • [Source: Phytomedicine, 2022]

Key Bioactive Compounds

• Silicic acid / Silica (5-10%): Connective tissue support; marker compound
• Flavonoids (0.2-0.9%): Quercetin, kaempferol, apigenin glycosides — diuretic and anti-inflammatory
• Phenolic acids: Caffeic acid, dicaffeoyl-meso-tartaric acid, chlorogenic acid
• Saponins: Equisetonin
• Alkaloids: Nicotine (trace), palustrine (absent in E. arvense, present in toxic E. palustre)
• Minerals: Potassium, manganese, calcium (in addition to silica)
• Sterols: Beta-sitosterol, campesterol

Clinical Evidence Summary

Carneiro et al. 2014 — Diuretic Effect Trial

• Design: Randomized, double-blind clinical trial
• Sample Size: n=36 healthy male volunteers
• Groups: 3 groups of 12, using crossover design
• Interventions (each for 4 consecutive days with 10-day washout):
  1. Standardized E. arvense dry extract (EADE): 900 mg/day (0.026% total flavonoids)
  2. Placebo: Corn starch 900 mg/day
  3. Active comparator: Hydrochlorothiazide 25 mg/day
• Results:
  • E. arvense extract produced diuretic effect stronger than placebo
  • E. arvense was equivalent to hydrochlorothiazide in diuretic effect
  • No significant changes in electrolyte elimination (unlike hydrochlorothiazide)
• Significance: The electrolyte-sparing diuretic effect is clinically meaningful — horsetail increases urine volume without depleting sodium, potassium, or chloride
• Limitations: Small sample, healthy volunteers only, short duration, single study
• [Source: Evidence-Based Complementary and Alternative Medicine, 2014, PMC3960516]

Antihypertensive Trial (2022)

• Double-blind, randomized clinical trial
• Assessed antihypertensive effect of E. arvense
• Results suggested blood pressure reduction
• [Source: Phytomedicine, ScienceDirect]

Evidence Limitations

• Only one rigorous RCT for diuretic effect (Carneiro 2014, n=36)
• No large-scale clinical trials
• No trials specifically in patients with UTI or urinary tract inflammation
• Traditional use evidence is strong but clinical trial evidence is preliminary
• The Carneiro finding of hydrochlorothiazide equivalence is striking but needs replication

European vs US/Anglophone Consensus

Safety Profile

Contraindications

• Conditions requiring reduced fluid intake (cardiac insufficiency, severe renal failure) — because irrigation therapy requires high fluid intake
• Edema due to impaired cardiac or renal function
• Known hypersensitivity to Equisetum species

Drug Interactions

• Diuretics: Additive diuretic effect; monitor fluid/electrolyte balance
• Lithium: May alter lithium excretion (as with other diuretics)
• Cardiac glycosides (digoxin): Theoretical risk if electrolyte imbalance occurs (though Carneiro 2014 showed no electrolyte effect)
• Antihypertensives: Possible additive hypotensive effect
• Thiamine (Vitamin B1): Horsetail contains thiaminase, which can degrade thiamine. Chronic use may deplete B1 stores [UNCERTAIN — more relevant with raw plant consumption than standardized extracts]

Side Effects

• Rare: GI disturbances (nausea, diarrhea)
• Theoretical: Thiamine depletion with prolonged use
• Species confusion risk: If E. palustre (marsh horsetail) is inadvertently substituted for E. arvense, toxic palustrine alkaloids may be present. This is a supply chain/quality control issue rather than an inherent risk of E. arvense

Pregnancy/Lactation

• Not recommended: Insufficient safety data
• No evidence of specific harm, but traditional precautionary avoidance
• Not studied in pregnant or lactating populations

Clinical Dosage

Standardized Dosage Forms

Standardization

• Standardized to total flavonoid content (Carneiro 2014 used extract with 0.026% total flavonoids)
• Silica content (5-10% as marker, though not necessarily the active diuretic principle)
• European Pharmacopoeia specifies minimum total flavonoid content

Key Products

• Natterman Bronchitol (Netherlands): Contains horsetail (though primarily for respiratory use)
• Various German pharmacy teas containing Equiseti herba
• Often included in combination diuretic/irrigation therapy formulations with goldenrod and/or birch leaf

Critical: Fluid Intake Requirement

• As with all irrigation therapy herbs: minimum 2 liters/day fluid intake is mandatory
• The therapeutic effect depends on herb + adequate fluid volume

Duration of Treatment

• Short-term use recommended (weeks, not months)
• Concern about thiaminase-mediated B1 depletion with very long-term use
• Consult physician if symptoms do not improve within 2 weeks

Sources

• EMA Assessment Report on Equisetum arvense herba
• EMA Herbal Monograph on Equisetum arvense
• EMA Public Summary — Horsetail
• ESCOP Monograph — Equiseti herba
• Carneiro et al. 2014 — Diuretic Trial (PMC)
• Equisetum arvense Review (Pharmacognosy Reviews)
• Antihypertensive Trial (ScienceDirect)
• Altmeyers Encyclopedia — Equiseti herba

Connections

• See Goldenrod and Birch Leaf for other irrigation therapy herbs
• See Bearberry Uva Ursi for a urinary antiseptic (different mechanism)